Isopropyl palmitate, min. 90%, for synthesis, 1 l, plastic packaging.

6-bromo-8-(pyrrolidin-1-yl)-1,2,3,4-tetrahydro-1,5-naphthyridine, 95.0%, 500mg

(4-Butoxy-2-fluorophenyl)boronic acid, 95.0%, 1g

1-Phenyl-5-(pyridin-2-yl)-2(1H)-pyridone, 95%, 25g

tert-Butyl 3,3-difluoro-4-(((trifluoromethyl)sulfonyl)oxy)-3,6-dihydropyridine-1(2H)-carboxylate, 98%, 10g

Quinoxaline, 98.00%, 10g

1-Amino-3-phenylpropan-2-one hydrochloride, 98%, 250mg

1-Chloro-2-pentanone, 95%, 250mg

Sodium 8-fluoro-[1,2,4]triazolo[4,3-a]pyridine-3-carboxylate, 1g

(3-(Dimethylamino)-4-fluorophenyl)boronic acid, 98%, 250mg

cyclobutyl 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone, 97.0%, 1g

2-Methyl-D-Serine, 95.0%, 100mg

2-Chloro-5-methyl-pyridine-3-sulfonyl chloride, 95.0%, 500mg